Epstein-barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP

Agnes I. Wycisk, Jiacheng Lin, Sandra Loch, Kathleen Hobohm, Jessica Funke, Ralph Wieneke, Joachim Koch, William Skach, Peter U. Mayerhofer, Robert Tampé

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Virus-infected cells are eliminated by cytotoxic T lymphocytes, which recognize viral epitopes displayed on major histocompatibility complex class I molecules at the cell surface. Herpesviruses have evolved sophisticated strategies to escape this immune surveillance. During the lytic phase of EBV infection, the viral factor BNLF2a interferes with antigen processing by preventing peptide loading of major histocompatibility complex class I molecules. Here we reveal details of the inhibition mechanism of this EBV protein.Wedemonstrate that BNLF2a acts as a tail-anchored protein, exploiting the mammalian Asna-1/WRB (Get3/Get1) machinery for posttranslational insertion into the endoplasmic reticulum membrane, where it subsequently blocks antigen translocation by the transporter associated with antigen processing (TAP). BNLF2a binds directly to the core TAP complex arresting the ATP-binding cassette transporter in a transport-incompetent conformation. The inhibition mechanism of EBV BNLF2a is distinct and mutually exclusive of other viral TAP inhibitors.

Original languageEnglish (US)
Pages (from-to)41402-41412
Number of pages11
JournalJournal of Biological Chemistry
Volume286
Issue number48
DOIs
StatePublished - Dec 2 2011

Fingerprint

Antigen Presentation
Viral Proteins
Major Histocompatibility Complex
Human Herpesvirus 4
Machinery
Antigens
Molecules
Epstein-Barr Virus Infections
ATP-Binding Cassette Transporters
T-cells
Herpesviridae
Cytotoxic T-Lymphocytes
Processing
Viruses
Endoplasmic Reticulum
Conformations
Epitopes
Proteins
Membranes
Peptides

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Epstein-barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP. / Wycisk, Agnes I.; Lin, Jiacheng; Loch, Sandra; Hobohm, Kathleen; Funke, Jessica; Wieneke, Ralph; Koch, Joachim; Skach, William; Mayerhofer, Peter U.; Tampé, Robert.

In: Journal of Biological Chemistry, Vol. 286, No. 48, 02.12.2011, p. 41402-41412.

Research output: Contribution to journalArticle

Wycisk, AI, Lin, J, Loch, S, Hobohm, K, Funke, J, Wieneke, R, Koch, J, Skach, W, Mayerhofer, PU & Tampé, R 2011, 'Epstein-barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP', Journal of Biological Chemistry, vol. 286, no. 48, pp. 41402-41412. https://doi.org/10.1074/jbc.M111.237784
Wycisk, Agnes I. ; Lin, Jiacheng ; Loch, Sandra ; Hobohm, Kathleen ; Funke, Jessica ; Wieneke, Ralph ; Koch, Joachim ; Skach, William ; Mayerhofer, Peter U. ; Tampé, Robert. / Epstein-barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP. In: Journal of Biological Chemistry. 2011 ; Vol. 286, No. 48. pp. 41402-41412.
@article{a9bd4ad18fcf48e8a49737770e7c71ec,
title = "Epstein-barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP",
abstract = "Virus-infected cells are eliminated by cytotoxic T lymphocytes, which recognize viral epitopes displayed on major histocompatibility complex class I molecules at the cell surface. Herpesviruses have evolved sophisticated strategies to escape this immune surveillance. During the lytic phase of EBV infection, the viral factor BNLF2a interferes with antigen processing by preventing peptide loading of major histocompatibility complex class I molecules. Here we reveal details of the inhibition mechanism of this EBV protein.Wedemonstrate that BNLF2a acts as a tail-anchored protein, exploiting the mammalian Asna-1/WRB (Get3/Get1) machinery for posttranslational insertion into the endoplasmic reticulum membrane, where it subsequently blocks antigen translocation by the transporter associated with antigen processing (TAP). BNLF2a binds directly to the core TAP complex arresting the ATP-binding cassette transporter in a transport-incompetent conformation. The inhibition mechanism of EBV BNLF2a is distinct and mutually exclusive of other viral TAP inhibitors.",
author = "Wycisk, {Agnes I.} and Jiacheng Lin and Sandra Loch and Kathleen Hobohm and Jessica Funke and Ralph Wieneke and Joachim Koch and William Skach and Mayerhofer, {Peter U.} and Robert Tamp{\'e}",
year = "2011",
month = "12",
day = "2",
doi = "10.1074/jbc.M111.237784",
language = "English (US)",
volume = "286",
pages = "41402--41412",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "48",

}

TY - JOUR

T1 - Epstein-barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP

AU - Wycisk, Agnes I.

AU - Lin, Jiacheng

AU - Loch, Sandra

AU - Hobohm, Kathleen

AU - Funke, Jessica

AU - Wieneke, Ralph

AU - Koch, Joachim

AU - Skach, William

AU - Mayerhofer, Peter U.

AU - Tampé, Robert

PY - 2011/12/2

Y1 - 2011/12/2

N2 - Virus-infected cells are eliminated by cytotoxic T lymphocytes, which recognize viral epitopes displayed on major histocompatibility complex class I molecules at the cell surface. Herpesviruses have evolved sophisticated strategies to escape this immune surveillance. During the lytic phase of EBV infection, the viral factor BNLF2a interferes with antigen processing by preventing peptide loading of major histocompatibility complex class I molecules. Here we reveal details of the inhibition mechanism of this EBV protein.Wedemonstrate that BNLF2a acts as a tail-anchored protein, exploiting the mammalian Asna-1/WRB (Get3/Get1) machinery for posttranslational insertion into the endoplasmic reticulum membrane, where it subsequently blocks antigen translocation by the transporter associated with antigen processing (TAP). BNLF2a binds directly to the core TAP complex arresting the ATP-binding cassette transporter in a transport-incompetent conformation. The inhibition mechanism of EBV BNLF2a is distinct and mutually exclusive of other viral TAP inhibitors.

AB - Virus-infected cells are eliminated by cytotoxic T lymphocytes, which recognize viral epitopes displayed on major histocompatibility complex class I molecules at the cell surface. Herpesviruses have evolved sophisticated strategies to escape this immune surveillance. During the lytic phase of EBV infection, the viral factor BNLF2a interferes with antigen processing by preventing peptide loading of major histocompatibility complex class I molecules. Here we reveal details of the inhibition mechanism of this EBV protein.Wedemonstrate that BNLF2a acts as a tail-anchored protein, exploiting the mammalian Asna-1/WRB (Get3/Get1) machinery for posttranslational insertion into the endoplasmic reticulum membrane, where it subsequently blocks antigen translocation by the transporter associated with antigen processing (TAP). BNLF2a binds directly to the core TAP complex arresting the ATP-binding cassette transporter in a transport-incompetent conformation. The inhibition mechanism of EBV BNLF2a is distinct and mutually exclusive of other viral TAP inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=82355184481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82355184481&partnerID=8YFLogxK

U2 - 10.1074/jbc.M111.237784

DO - 10.1074/jbc.M111.237784

M3 - Article

C2 - 21984826

AN - SCOPUS:82355184481

VL - 286

SP - 41402

EP - 41412

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 48

ER -